Brief: Rallybio Q3 Net Income USD -11.466 Million
07/11/2024 13:00
Nov 07 (Reuters) - Rallybio Q3 operating expenses USD 12.365 million. * Q3 basic EPS USD -0.26 * Q3 income from operations USD -12.066 million
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx